Guardant Health
GH
#1121
Rank
A$30.56 B
Marketcap
A$225.94
Share price
-2.17%
Change (1 day)
50.79%
Change (1 year)
Guardant Health is an American company developing blood tests for early detection in high-risk populations and recurrence monitoring in cancer survivors.

Guardant Health (GH) - Total liabilities

Total liabilities on the balance sheet as of June 2026 : A$3.10 Billion

According to Guardant Health 's latest financial reports the company's total liabilities are A$3.10 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Guardant Health - Total liabilities on balance sheet (from 2017 to 2024)

Total liabilities by year

Year Total liabilities Change
2023-12-31A$2.38 B4.91%
2022-12-31A$2.27 B5.87%
2021-12-31A$2.15 B80.53%
2020-12-31A$1.19 B628.31%
2019-12-31A$0.16 B84.55%
2018-12-31A$88.64 M101.59%
2017-12-31A$43.97 M-14.02%
2016-12-31A$51.14 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Neogen
NEOG
A$1.76 B-43.01%๐Ÿ‡บ๐Ÿ‡ธ USA
Natera
NTRA
A$1.21 B-60.85%๐Ÿ‡บ๐Ÿ‡ธ USA